AstraZeneca PLC (AZN.L)
LSE
Healthcare
Drug Manufacturers - General
$12548.00
▼ -0.49%
Market Cap
$194.60B
Sector
Healthcare
Industry
Drug Manufacturers - General
Beta
0.23
52-Wk Range
10178-15732
CEO
Pascal Claude Roland Soriot
Country
GB
Currency
GBp
AstraZeneca PLC operates as a biopharmaceutical company, specializing in the discovery, development, manufacturing, and commercialization of prescription medications. Its comprehensive portfolio addresses diverse therapeutic areas. In oncology, key marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex. For cardiovascular, renal, and metabolism diseases, the company offers treatments such as Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Ongl…
Open full interactive analysis & DCF →